Oligonucleotide Synthesis Market by Product and Service (Synthesizer, Custom Oligonucleotide Synthesis Service, Probes, Primers, Linkers and Adaptor, Reagents and Consumables), Application (Research, Therapeutics, Diagnostics), and End User - Global Forecast to 2025

  • Report ID:MRHC - 104252
  • Pages: 200
  • Jan 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction 
    1.1. Market Ecosystem  
    1.2. Currency & Limitation   
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders 

2. Research Methodology 
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.3. Market Size Estimation

3. Executive Summary 

4. Market Insights 
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers 
                    4.2.1.1. Growing Adoption of Synthesized Oligonucleotides in Diagnostics and Clinical Applications 
                    4.2.1.2. Rising R&D Expenditure and Government Investment in Pharmaceutical and Biotechnology Companies 
                    4.2.1.3. Plummeting Cost of Sequencing 
                    4.2.1.4. Increasing Public-Private Spending on Genomics 
                    4.2.1.5. Rising Venture Capital Investments/Funding 
           4.2.2. Restraints 
                    4.2.2.1. Lack of Regulations for Therapeutic Oligos 
                    4.2.2.2. Price Erosion of Synthesized Oligonucleotides 
           4.2.3. Opportunities
                    4.2.3.1. Emerging Asian Markets 
                    4.2.3.2. Therapeutic Oligos 
           4.2.4. Challenges  
                    4.2.4.1. Large-Scale Synthesis of Oligonucleotides 
                    4.2.4.2. Delivery of Oligonucleotide Drugs to Specific Targets
 
5. Oligonucleotide Synthesis Market, by Product & Services
    5.1. Introduction 
    5.2. Oligonucleotide Synthesis Products
           5.2.1. Oligonucleotide Synthesis Equipment (Synthesizers)
           5.2.2. Oligonucleotide Synthesis Reagents & Consumables 
    5.3. Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
           5.3.1. Primers
           5.3.2. Probes
           5.3.3. Linkers & Adaptors
    5.4. Custom Oligonucleotide Synthesis Services (Custom Oligonucleotides)
           5.4.1. Large-Scale Oligonucleotide Synthesis
           5.4.2. Intermediate-Scale Oligonucleotide Synthesis
           5.4.3. Small-Scale Oligonucleotide Synthesis

6. Oligonucleotide Synthesis Market, by Application 
    6.1. Introduction 
    6.2. Research  
           6.2.1. PCR 
           6.2.2. qPCR/RTqPCR 
           6.2.3. Sequencing 
           6.2.4. Gene Synthesis
           6.2.5. Other Research Applications 
    6.3. Diagnostics 
    6.4. Therapeutics  
           6.4.1. RNAi Oligonucleotide-based Therapies
           6.4.2. DNA/Antisense Oligonucleotide-based Therapies 
           6.4.3. Immunotherapy (CpG Oligonucleotide-based Therapies) 
           6.4.4. Nucleic Acid Aptamers 

7. Oligonucleotide Synthesis Market, by End User 
    7.1. Introduction 
    7.2. Pharmaceutical and Biotechnology Companies  
    7.3. Academic Research Institutes  
    7.4. Diagnostic Laboratories  
    7.5. Others
 
8. Oligonucleotide Synthesis Market, by Geography  
    8.1. North America 
           8.1.1. U.S.
           8.1.2. Canada
    8.2. Europe 
           8.2.1. Germany 
           8.2.2. France
           8.2.3. U.K.
           8.2.4. Italy
           8.2.5. Spain
           8.2.6. Rest of Europe
    8.3. Asia-Pacific  
           8.3.1. Japan
           8.3.2. China
           8.3.3. India
           8.3.4. Rest of Asia-Pacific
    8.4. Rest of the World 
           8.4.1. Latin America
           8.4.2. Middle East & Africa

9. Competitive Landscape
    9.1. Introduction
    9.2. Key Growth Strategies
    9.3. Competitive Benchmarking
    9.4. Market Share Analysis (2018)
           9.4.1. Integrated DNA Technologies, Inc.
           9.4.2. Eurofins Scientific Se
           9.4.3. Thermo Fisher Scientific Inc.
           9.4.4. Agilent Technologies, Inc. 

10. Company Profiles 
      10.1. Danaher Corporation 
              10.1.1. Business Overview
              10.1.2. Financial Overview   
              10.1.3. Product Portfolio    
              10.1.4. Strategic Developments   
      10.2. Merck KGaA (Sigma-Aldrich Co. LLC) 
              10.2.1. Business Overview
              10.2.2. Financial Overview    
              10.2.3. Product Portfolio     
              10.2.4. Strategic Developments 
      10.3. Eurofins Genomics LLC (Part of Eurofins Scientific SE)
              10.3.1. Business Overview    
              10.3.2. Financial Overview    
              10.3.3. Product Portfolio 
              10.3.4. Strategic Developments 
      10.4. Thermo Fisher Scientific, Inc. 
              10.4.1. Business Overview     
              10.4.2. Financial Overview    
              10.4.3. Products Portfolio
              10.4.4. Strategic Developments
      10.5. Agilent Technologies, Inc. 
              10.5.1. Business Overview    
              10.5.2. Financial Overview    
              10.5.3. Product Portfolio
              10.5.4. Strategic Developments
      10.6. GE Healthcare 
              10.6.1. Business Overview     
              10.6.2. Financial Overview    
              10.6.3. Product Portfolio
              10.6.4. Strategic Developments
      10.7. GeneDesign Inc. (Part of Ajinomoto Co., Inc.)  
              10.7.1. Business Overview     
              10.7.2. Financial Overview     
              10.7.3. Product Portfolio
              10.7.4. Strategic Developments
      10.8. Kaneka Eurogentec S.A. (Part of Kaneka Corporation)
              10.8.1. Business Overview
              10.8.2. Financial Overview 
              10.8.3. Products Portfolio
              10.8.4. Strategic Developments
      10.9. LGC Biosearch Technologies 
              10.9.1. Business Overview     
              10.9.2. Financial Overview     
              10.9.3. Product Portfolio
              10.9.4. Strategic Developments
      10.10. Bio-synthesis Inc. 
                10.10.1. Business Overview 
                10.10.2. Financial Overview          
                10.10.3. Product Portfolio
                10.10.4. Strategic Developments
      10.11. Twist Bioscience Corporation
                10.11.1. Business Overview
                10.11.2. Financial Overview
                10.11.3. Product Portfolio
                10.11.4. Strategic Developments
      10.12. LGC Biosearch Technologies
                10.12.1. Business Overview
                10.12.2. Financial Overview
                10.12.3. Product Portfolio
                10.12.4. Strategic Developments
      10.13. Bio-Synthesis Inc.
                10.13.1. Business Overview
                10.13.2. Financial Overview
                10.13.3. Product Portfolio
      10.14. ATDBio Ltd.
                10.14.1. Business Overview
                10.14.2. Financial Overview
                10.14.3. Product Portfolio

11. Appendix
      11.1. Questionnaire
      11.2. Available Customization

List of Tables
Table 1 Oligonucleotide Synthesis Market Drivers: Impact Analysis (2018–2025)
Table 2 Global Oligonucleotide Synthesis Market Restraints: Impact Analysis (2018-2025)
Table 3 Global Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 4 Global Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 5 Global Oligonucleotide Synthesis Products Market Size, by Country, 2017-2025 ($Million)
Table 6 Global Oligonucleotide Synthesizers Market Size, by Country, 2017-2025 ($Million)
Table 7 Global Oligonucleotide Synthesis Reagents & Consumables Market Size, by Country, 2017-2025 ($Million)
Table 8 Global Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 9 Global Synthesized Oligonucleotides Market Size, by Country, 2017-2025 ($Million)
Table 10 Global Synthesized Oligonucleotide Primers Market Size, by Country, 2017-2025 ($Million)
Table 11 Global Synthesized Oligonucleotide Probes Market Size, by Country, 2017-2025 ($Million)
Table 12 Global Synthesized Oligonucleotide Linkers and Adapters Market Size, by Country, 2017-2025 ($Million)
Table 13 Global Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 14 Global Custom Oligonucleotide Synthesis Services Market Size, by Country, 2017-2025 ($Million)
Table 15 Global Large-Scale Oligonucleotide Synthesis Services Market Size, by Country, 2017-2025 ($Million)
Table 16 Global Intermediate-Scale Oligonucleotide Synthesis Services Market Size, by Country, 2017-2025 ($Million)
Table 17 Global Small-Scale Synthesis Oligonucleotide Synthesis Services Market Size, by Country, 2017-2025 ($Million)
Table 18 Global Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 19 Global Oligonucleotide Synthesis Market Size for Research, by Country, 2017-2025 ($Million)
Table 20 Global Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 21 Global Oligonucleotide Synthesis Market Size for PCR, by Country, 2017-2025 ($Million)
Table 22 Global Oligonucleotide Synthesis Market Size for qPCR/RTqPCR, by Country, 2017-2025 ($Million)
Table 23 Global Oligonucleotide Synthesis Market Size for Sequencing, by Country, 2017-2025 ($Million)
Table 24 Global Oligonucleotide Synthesis Market Size for Gene Synthesis, by Country, 2017-2025 ($Million)
Table 25 Global Oligonucleotide Synthesis Market Size for Other Research Applications, by Country, 2017-2025 ($Million)
Table 26 Global Oligonucleotide Synthesis Market Size for Diagnostics, by Country, 2017-2025 ($Million)
Table 27 Global Oligonucleotide Synthesis Market Size for Therapeutics, by Country, 2017-2025 ($Million)
Table 28 Global Oligonucleotide Synthesis Market Size for Therapeutic, by Type, 2017-2025 ($Million)
Table 29 Global Oligonucleotide Synthesis Market Size for RNAi Therapies, by Country, 2017-2025 ($Million)
Table 30 Global Oligonucleotide Synthesis Market Size for Antisense Oligonucleotides Therapies,
Table 31 Global Oligonucleotide Synthesis Market Size for Immunotherapy, by Country, 2017-2025 ($Million)
Table 32 Global Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamers, by Country, 2017-2025 ($Thousand)
Table 33 Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 34 Global Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, by Country, 2017-2025 ($Million)
Table 35 Global Oligonucleotides Synthesis Market Size for Academic Research Institutes, by Country, 2017-2025 ($Million)
Table 36 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, by Country, 2017-2025 ($Million)
Table 37 Global Oligonucleotide Synthesis Market Size for Other End Users, by Country, 2017-2025 ($Million)
Table 38 Global Oligonucleotide Synthesis Market Size, by Geography, 2017-2025 ($Million)
Table 39 North America: Oligonucleotide Synthesis Market Size, by Country, 2017-2025 ($Million)
Table 40 North America: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 41 North America: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 42 North America: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 43 North America: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 44 North America: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 45 North America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 46 North America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 47 North America: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 48 U.S.: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 49 U.S.: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 50 U.S.: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 51 U.S.: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 52 U.S.: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 53 U.S.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 54 U.S.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 55 U.S.: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 56 Canada: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 57 Canada: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 58 Canada: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 59 Canada: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 60 Canada: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 61 Canada: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 62 Canada: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 63 Canada: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 64 Europe: Oligonucleotide Synthesis Market Size, by Country, 2017-2025 ($Million)
Table 65 Europe: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 66 Europe: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 67 Europe: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 68 Europe: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 69 Europe: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 70 Europe: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 71 Europe: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 72 Europe: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 73 Germany: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 74 Germany: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 75 Germany: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 76 Germany: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 77 Germany: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 78 Germany: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 79 Germany: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 80 Germany: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 81 France: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 82 France: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 83 France: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 84 France: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 85 France: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 86 France: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 87 France: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 88 France: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 89 U.K.: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 90 U.K.: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 91 U.K.: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 92 U.K.: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 93 U.K.: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 94 U.K.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 95 U.K.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 96 U.K.: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 97 Italy: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 98 Italy: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 99 Italy: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 100 Italy: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 101 Italy: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 102 Italy: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 103 Italy: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 104 Italy: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 105 Spain: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 106 Spain: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 107 Spain: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 108 Spain: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 109 Spain: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 110 Spain: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 111 Spain: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 112 Spain: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 113 RoE: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 114 RoE: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 115 RoE: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 116 RoE: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 117 RoE: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 118 RoE: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 119 RoE: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 120 RoE: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 121 APAC: Oligonucleotide Synthesis Market Size, by Country, 2017-2025 ($Million)
Table 122 APAC: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 123 APAC: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 124 APAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 125 APAC: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 126 APAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 127 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 128 APAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 129 APAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 130 China: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 131 China: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 132 China: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 133 China: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 134 China: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 135 China: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 136 China: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 137 China: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 138 Japan: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 139 Japan: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 140 Japan: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 141 Japan: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 142 Japan: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 143 Japan: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 144 Japan: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 145 Japan: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 146 India: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 147 India: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 148 India: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 149 India: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 150 India: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 151 India: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 152 India: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 153 India: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 154 RoAPAC: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 155 RoAPAC: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 156 RoAPAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 157 RoAPAC: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 158 RoAPAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 159 RoAPAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 160 RoAPAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 161 RoAPAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 162 RoW: Oligonucleotide Synthesis Market Size, by Region, 2017-2025 ($Million)
Table 163 RoW: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 164 RoW: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 165 RoW: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 166 RoW: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 167 RoW: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 168 RoW: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 169 RoW: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 170 RoW: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 171 Latin America: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 172 Latin America: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 173 Latin America: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 174 Latin America: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 175 Latin America: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 176 Latin America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 177 Latin America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 178 Latin America: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 179 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2025 ($Million)
Table 180 Middle East & Africa: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2025 ($Million)
Table 181 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Type, 2017-2025 ($Million)
Table 182 Middle East & Africa: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2025 ($Million)
Table 183 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Application, 2017-2025 ($Million)
Table 184 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2025 ($Million)
Table 185 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2025 ($Million)
Table 186 Middle East & Africa: Oligonucleotide Synthesis Market Size, by End User, 2017-2025 ($Million)
Table 187 Number of Developments by the Major Players during 2015-2018
Table 188 Key Products: Synthesized Oligonucleotides


List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Key Findings: Oligonucleotide Synthesis Market
Figure 5 Global Oligonucleotide Synthesis Market, by Product, 2019-2025 ($Million)
Figure 6 Global Oligonucleotide Synthesis Market, by Application, 2019-2025 ($ Million)
Figure 7 Global Oligonucleotide Synthesis Market, by Region, 2018 (%)
Figure 8 Market Dynamics
Figure 9 Share of Medical and Health R&D Expenditure of U.S., by Type of Organization: 2017
Figure 10 Global Oligonucleotide Synthesis Market Size, by Product, 2019-2025 ($Million)
Figure 11 Synthesized Oligonucleotides Market Size, by Product, 2019-2025 ($Million)
Figure 12 Oligonucleotide Synthesis Products Market Size, by Type, 2019-2025 ($Million)
Figure 13 Custom Oligonucleotide Synthesis Services Market Size, by Type, 2019-2025 ($Million)
Figure 14 Global Oligonucleotide Synthesis Market Size, by Application, 2019-2025 ($Million)
Figure 15 Global Oligonucleotide Synthesis Market Size, by End User, 2019-2025 ($Million)
Figure 16 Pharmaceutical R&D Spending by PhRMA Member Companies, 2015-2017 ($Billion)
Figure 17 Global Oligonucleotide Synthesis Market Size, by Geography, 2019-2025 ($Million)
Figure 18 North America: Oligonucleotide Synthesis Market Size, by Country, 2019-2025 ($Million)
Figure 19 Number of People with Chronic Diseases in America: 2005-2030 (Million)
Figure 20 Number of People Aged 60 Years or Over in Europe, In 2017 Vs 2050 (In Million)
Figure 21 Europe: Oligonucleotide Synthesis Market Size, by Country, 2019-2025 ($Million)
Figure 22 Number of Biotech Companies in Germany by Their Key Business Focus, 2017
Figure 23 Spain: Proportion of Overweight Population (In %), 2000-2020
Figure 24 Life Expectancy in Spain Compared to Other EU Countries, 2000-2015
Figure 25 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 26 APAC: Oligonucleotide Synthesis Market Size, by Country, 2019-2025 ($Million)
Figure 27 Share of Non-Communicable Diseases in Total Deaths in China, 2005-2020 (%)
Figure 28 Japan: Share of Population Aged 65 Years & Above, 1950-2050 (%)
Figure 29 Growth Strategies Adopted by the Key Players between 2016 and 2019
Figure 30 Oligonucleotide Synthesis Market: Competitive Benchmarking
Figure 31 Market Share Analysis: Oligonucleotide Synthesis Industry, 2018
Figure 32 Danaher Corporation: Financial Overview-2016-2018
Figure 33 Merck KGaA: Financial Overview-2016-2018
Figure 34 Eurofins Scientific SE: Financial Overview-2016-2018
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview-2016-2018
Figure 36 Agilent Technologies, Inc.: Financial Overview-2016-2018
Figure 37 GE Healthcare: Financial Overview-2016-2018
Figure 38 GenScript Biotech Corporation: Financial Overview-2016-2019
Figure 39 Ajinomoto Co., Inc.: Financial Overview-2017-2019
Figure 40 Kaneka Corporation: Financial Overview-2017-2019
Figure 41 Maravai LifeSciences: Financial Overview-2017-2019
Figure 42 Twist Bioscience Corporation: Financial Overview-2017-2019


The global oligonucleotide synthesis market is expected to grow at a CAGR 10.4% from 2019 to 2025 to reach $3.9 billion by 2025.

The global oligonucleotide synthesis market is highly competitive and provides robust growth opportunities for biotechnology companies. The growth in this market is mainly attributed to the growing adoption of synthesized oligonucleotides in diagnostic and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology research, plummeting cost of sequencing, increasing public and private spending on genomics, and rising venture capital investments/funding. In recent years, this market has witnessed significant rise in acquisition of various small-scale oligonucleotide synthesis companies by major key players, to broaden their product & service offerings and expand their presence in the oligonucleotide synthesis market.

Plummeting cost of sequencing to fuel the growth of the oligonucleotide synthesis market

The advancements in the field of genomics research over the past few years have led to the substantial reduction in the cost of genome sequencing. The NGS technology has reduced the cost and increased the speed of DNA sequencing significantly. According to the statistics from the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has decreased substantially from approximately $5 million in 2008 to approximately $1,000 in 2017. In the field of genomics research, sequencing is increasingly being used not only to assemble genomes and to investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. Thus, the rapidly plummeting cost of sequencing is expected to further boost the research activities, thereby fueling the demand of oligonucleotide synthesis products and technologies during the forecast period.

                                              Click here to: Get Free Request Sample Pages of this report

Emerging Asian market offers significant opportunities to support the market growth

Various developed countries like the U.S. and European nations have been the key markets for various stakeholders in the oligonucleotide synthesis market. However, low penetrated emerging economies are expected to offer significant growth over the coming years, through rising demand for oligonucleotides with increasing funding for R&D projects; rising proteomics, genomics, and metabolomics research; rising healthcare expenditure; and ongoing developments in the healthcare infrastructure.

The emerging economies such as China, India, and Association of Southeast Asian Nations (ASEAN) member countries in the Asia-pacific region have been identified as highly lucrative markets by various stakeholders in the oligonucleotide synthesis market since last few years. In China, the demand for genetic sequencing is booming, fueled by country’s growing middle class, aging population, and expanding healthcare system. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative—a 14-year, $9.2 billion project to sequence more than 100 million human genomes by 2030.

Key findings in the global oligonucleotide synthesis market study:

Oligonucleotide synthesis products dominate the oligonucleotide synthesis market, by product

In 2019, the oligonucleotide synthesis products segment is estimated to account for the largest share of the overall oligonucleotide synthesis market. The wide use of synthesizers and consumables like PCR primers in PCR studies have led to a greater share of synthesis products. Huge adoption of PCR technologies across research and diagnostic fields owing to their ease, high sensitivity, and cost effectiveness are further supporting the growth in this segment.

Research segment dominates the global oligonucleotide synthesis market, by application

On the basis of application, research segment is estimated to command the largest share of the overall oligonucleotide synthesis market in 2019. However, use of oligonucleotides for diagnostic applications is likely to grow at the fastest CAGR during the forecast period mainly due to developing applications of molecular diagnostics (MDx) and genetic testing.

Diagnostic laboratories to register the fastest CAGR

On the basis of end-user, oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The diagnostic laboratory's end-user segment is expected to register the fastest CAGR during the forecast period owing to rising application of oligonucleotide in diagnostic applications.

North America dominates the global oligonucleotide synthesis market

In 2019, North America is estimated to dominate the global oligonucleotide synthesis market, followed by Europe. However, the demand from Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period. Increasing availability of synthesized oligonucleotides, strong presence of pharma & biotech companies, growing research outsourcing to CROs, and increase in R&D funding and activities are some of the major factors supporting the growth of the oligonucleotides market in the APAC region.

Your browser does not support the canvas element.

Key Players

The key players operating in the global oligonucleotide synthesis market are Integrated DNA Technologies, Inc. (U.S.) (Part of Danaher Corporation), Merck KGaA (Germany), Eurofins Scientific SE (Luxembourg), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan) (Part of Ajinomoto Co.,Inc.), Kaneka Eurogentec (Belgium) (Part of Kaneka Corporation), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.) (Part of Maravai LifeSciences), and ATDBio Ltd. (U.K.) among others.

Scope of the Report:

Oligonucleotide Synthesis Market, by Product & Services

  • Oligonucleotide Synthesis Products
    • Oligonucleotide Synthesis Equipment (Synthesizers)
    • Oligonucleotide Synthesis Reagents & Consumables
  • Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
    • Primers
    • Probes
    • Linkers & Adaptors
  • Custom Oligonucleotide Synthesis Services (Custom Oligonucleotides)
    • Large-Scale Oligonucleotide Synthesis
    • Intermediate-Scale Oligonucleotide Synthesis
    • Small-Scale Oligonucleotide Synthesis

Oligonucleotide Synthesis Market, by Application

  • Research
    • PCR
    • qPCR/RTqPCR
    • Sequencing
    • Gene Synthesis
    • Other Research Applications
  • Diagnostics
  • Therapeutics
    • RNAi Oligonucleotide-based Therapies
    • DNA/Antisense oligonucleotide-based Therapies
    • Immunotherapy (CpG Oligonucleotide-based Therapies)
    • Nucleic Acid Aptamers

Oligonucleotide Synthesis Market, by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Others

Oligonucleotide Synthesis Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

Growing adoption of synthesized oligonucleotides are expected to propel the overall oligonucleotide synthesis market

  • How does the penetration of synthesized oligonucleotides in developed regions differ from developing countries like China and India?
  • How is the competition between the major global and prominent local players in this market?
  • Which are the high growth market segments in terms of product, application, end-users, and geography?

Academic research institutes accounted for the largest share of the oligonucleotide synthesis market

  • What factors are contributing to the frequent usage of oligonucleotides in academic and research institutes?
  • How does the penetration of oligonucleotides in academic and research institutes differ from other end users?

Oligonucleotide synthesis market favors both the global and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain market shares?
  • Which market segments have the most potential for revenue expansion over the forecast period?
  • What are the major drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis market?
  • What are the geographical trends and which are the high growth regions/countries?

Recent partnerships, acquisitions, and expansions have taken place in the global oligonucleotide synthesis market

  • Which companies have recently merged/acquired; and how will these unions affect the competitive landscape of the oligonucleotide synthesis market?
  • Which companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global oligonucleotide synthesis market and what share of the market do they hold?
  • Who are the local emerging players in the global oligonucleotide synthesis market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample